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Knowledge of the functional cis-regulatory elements that regulate constitutive and alternative pre-mRNA splicing is
fundamental for biology and medicine. Here we undertook a genome-wide comparative genomics approach using
available mammalian genomes to identify conserved intronic splicing regulatory elements (ISREs). Our approach
yielded 314 ISREs, and insertions of ;70 ISREs between competing splice sites demonstrated that 84% of ISREs altered
59 and 94% altered 39 splice site choice in human cells. Consistent with our experiments, comparisons of ISREs to
known splicing regulatory elements revealed that 40%–45% of ISREs might have dual roles as exonic splicing silencers.
Supporting a role for ISREs in alternative splicing, we found that 30%–50% of ISREs were enriched near alternatively
spliced (AS) exons, and included almost all known binding sites of tissue-specific alternative splicing factors. Further,
we observed that genes harboring ISRE-proximal exons have biases for tissue expression and molecular functions that
are ISRE-specific. Finally, we discovered that for Nova1, neuronal PTB, hnRNP C, and FOX1, the most frequently
occurring ISRE proximal to an alternative conserved exon in the splicing factor strongly resembled its own known RNA
binding site, suggesting a novel application of ISRE density and the propensity for splicing factors to auto-regulate to
associate RNA binding sites to splicing factors. Our results demonstrate that ISREs are crucial building blocks in
understanding general and tissue-specific AS regulation and the biological pathways and functions regulated by these
AS events.
Citation: Yeo GW, Van Nostrand EL, Liang TY (2007) Discovery and analysis of evolutionarily conserved intronic splicing regulatory elements. PLoS Genet 3(5): e85. doi:10.
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Introduction
Considering that the human genome contains upwards of
20,000 genes with an average of eight to ten exons per gene, it
is remarkable that the RNA splicing machinery faithfully
distinguishes exons from intronic sequences that are 100- to
1,000-fold larger in size. Many studies show that the ﬁdelity of
splicing relies on cooperative interaction between the
splicesomal complex and splicing trans factors (reviewed in
[1]). Simple models of exon recognition depict trans factors
binding to splicing regulatory elements (SREs) in cis that are
in intronic regions proximal to the exon, or within the exon
itself, resulting in either increased exon usage (splicing
enhancers), or decreased splice site recognition (splicing
silencers) [2–4]. In addition to regulating constitutive splicing
(e.g., where a gene has only one isoform), SREs are also
important in regulating tissue-speciﬁc and developmentally
regulated alternative splicing events [2–4]. Evidence that as
many as 75% of human genes undergo alternative splicing,
whereby multiple isoforms are derived from the same genic
location, underscores the complexity of RNA splicing
regulation [5]. Last, a study restricted to analysis of the
canonical splice signals reported that 15% of point mutations
disrupted splicing [6], a likely gross underestimate of the
impact of splicing on human disease. A complete catalog of
SREs is necessary to improve our understanding of the
mechanisms controlling splicing, for it will enable rapid
diagnosis and treatment of splicing-associated diseases [7].
Recent work in the splicing ﬁeld has focused on establish-
ing a ‘‘splicing code’’ or a ‘‘parts list’’ of SREs [8]. Both
computational approaches and experimental screens have
made progress in identifying exonic splicing enhancers [9,10]
and exonic splicing silencers [10,11], of which several also
modulate splice site choice [12]. Recent computational results
have also suggested that intronic regions ﬂanking constitutive
exons contain potential splicing regulatory sequences [13–
15]. With the availability of multiple genomes, several
comparative genomics approaches have been applied to
identify exonic regulatory elements that affect alternative
and constitutive splicing in mammals [16], and intronic
regulatory elements that are proximal to alternative exons in
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(ESTs) and splicing-sensitive microarrays have been useful in
discovering cell type and tissue-speciﬁc included or skipped
alternative spliced exons [5,18–22]. Sequence analysis can be
used to derive tissue-speciﬁc SREs in the exonic regions or in
ﬂanking introns [18].
By exploiting evolutionary conservation of functional
elements, comparative genomics has proven effective in
identifying known and novel regulatory elements in non-
coding regions of mammalian genomes [23]. A recent study
identiﬁed regulatory motifs in the promoters and 39
untranslated regions of mammalian genes [24]. However,
the authors surveyed the last two introns of genes but
overlooked the intronic regions proximal to all exons [24].
Computational analyses of alternative exons that are evolu-
tionarily conserved in human and mouse indicated that up to
150 bases of intronic regions ﬂanking alternative exons in
both human and mouse have signiﬁcantly higher conserva-
tion than regions ﬂanking constitutive exons [25–27],
suggesting that they have a regulatory function.
Our goal is to systematically identify intronic splicing
regulatory elements (ISREs) that occurred frequently in the
intronic regions proximal to exons and that are conserved
across mammalian evolution. We subjected candidate ISREs
to a battery of computational analysis to discover their
biological functions, and experimentally tested almost a
quarter of predicted ISREs by splicing reporter assays, with
a validation rate of 84% for the downstream ISREs and 94%
for the upstream ISREs. While previous studies restricted
their analyses to exons that are predicted to be alternatively
spliced (AS) by alignments of ESTs, or to exons identiﬁed
from splicing-sensitive microarray experiments [17–19,27],
we believed a whole-genome comparative genomics approach
would yield an unbiased, comprehensive set of evolutionarily
important SREs.
Results/Discussion
Discovery of Conserved ISREs
Here, we describe our steps to identify conserved ISREs.
First, we generated a set of conserved exons and intronic
regions ﬂanking the exons. A total of ;17,870 isoform
clusters from the human RefSeq database were obtained from
the University of California Santa Cruz (UCSC) genome
browser. Next, ;2.7 million spliced human ESTs were aligned
to each cluster, and exon boundaries were extended to
generate a composite exon–intron structure for the cluster.
The mammalian exon dataset was generated by extracting
conserved (Homo sapiens, Canis familiaris, Rattus norvegicus, and
Mus musculus) internal exons from genome-wide multiple
alignments [28,29]. First exons were excluded, as the ﬁrst
introns of protein-coding genes are known to contain
transcription factor–binding sites, and may obscure the
search for SREs. In order to capture a sufﬁciently large
region while avoiding other functional elements, such as
microRNAs and snoRNAs, 400 bases of ﬂanking intronic
sequence proximal to both splice sites upstream and down-
stream of exons were targeted for analysis. Approximately
161,730 exons comprising 24.2 Mb of exonic sequence and
;129 Mb of intronic sequence were generated from the
human genome, not including the orthologous sequence
segments from other mammalian genomes.
Second, we counted the number of words (ﬁve to seven
bases in length) that were completely conserved in mammals
and the total number of occurrences in human, in the
intronic regions 400 bases downstream and 400 bases
upstream of all internal exons, respectively. We designated
a v
2 value to each word, which measured the relative
conservation rate of each word compared to all other words
of the same length. Next, we retained words that had
signiﬁcantly high v
2 values (p , 0.001, using a Bonferroni
correction for multiple hypothesis testing). For example, the
lowest scoring word of length 6 retained was GAAACT with a
conservation rate ;1.3-fold higher than background.
GAAACT had a v
2 score of 20.8, with an associated p value
of approximately 5 3 10
 6. This implied that out of 4,096
possible words of six bases in length, we did not expect to see
any words with an equal or higher score by chance. In order
to avoid identifying transcription factor–binding sites, we
repeated our procedure to extract signiﬁcantly conserved
words in a previously published dataset of promoter regions
aligned across the same mammalian genomes [24]. A total of
583 downstream and 630 upstream words from our intronic
screen were signiﬁcantly enriched in promoters, and were
discarded from further analysis. In all, 8.69%, 3%, and ;1%
of downstream words; and 9.3%, 3.3%, and 1.2% of upstream
words of ﬁve, six, and seven bases, respectively, scored
signiﬁcantly. In addition, approximately 25% of the signiﬁ-
cantly enriched words were common between upstream and
downstream words.
Third, we developed a score-based clustering procedure to
group the words into motif families, and deﬁned each family
as an ISRE. Our clustering procedure comprised four steps
(see Figure S1). In the ‘‘backward’’ step we compared all
longer words (e.g., seven bases) to shorter words (e.g., six
bases). A word was deﬁned as a ‘‘parent’’ of another word
(‘‘child’’) if it was a strict substring of the longer word and had
a higher v
2 score. In the ‘‘forward’’ step, we compared all
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Author Summary
During RNA splicing, sequences (introns) in a pre-mRNA are excised
and discarded, and the remaining sequences (exons) are joined to
form the mature RNA. Splicing is regulated not only by the binding
of the basic splicing machinery to splice sites located at the exon–
intron boundaries, but also by the combined effects of various other
splicing factors that bind to a multitude of sequence elements
located both in the exons as well as the flanking introns. Instances of
alternative splicing, where usage of splice site(s) is incomplete or
different between tissues, cell types, or lineages, can be created by
the interaction of sequence elements and tissue, cell type, and
stage-specific splicing factors. To better understand constitutive and
alternative pre-mRNA splicing, the authors describe a comparative
genomics approach, using available mammalian genomes, to
systematically identify splicing regulatory elements located in the
introns proximal to exons. A quarter of the elements were tested
experimentally, and most of them altered splicing in human cells.
The authors also showed that that the intronic elements are close to
tissue-specific alternative exons and are more likely to be located in
specific positions in the introns, suggestive of potential regulatory
function. These elements are also frequently found in tissue-specific
genes, suggesting a coupling between expression and alternative
splicing of these genes. Finally, the authors propose a strategy
using the elements to identify the binding sites of several splicing
factors.shorter words to longer words, and deﬁned a word as a child
of a longer word if it was a substring of the longer word and
had a lower v
2 score, and if it was already not a parent from
the backward step. Next, two families were ‘‘married’’ if they
shared more than half of their children. The parent with the
higher v
2 score was designated the new parent; the other
parent became a child in the family. Two families were
combined if parents had ﬁve bases in common, and if all
children of the lower scoring parent had ﬁve bases in
common with the higher-scoring parent. Again, the parent
with the higher v
2 score was designated the new parent. If a
child had more than one ﬁnal parent it was uniquely
associated with the highest-scoring parent. Our clustering
strategy had several features. First, it ensured that the parent
and thus representative of a motif family had the highest
conservation rate in the family. Second, words were grouped
by similarity to an actual word(s), which existed in biological
sequence and can be experimentally veriﬁed, and not to a
statistical average of the words, such as in positional weight
matrices (PWMs). Using a weight-matrix approach has the
limitation that high-scoring sequences with a weight matrix
may never occur in reality. In this paper we used a weight-
matrix representation for visualization purposes, but as much
as possible retained groups of words for an ISRE during
enumeration and experimental validation. An important
caveat in our analysis is that on occasion we had more than
one cluster with motifs that might have been grouped as one
cluster by other clustering methods. We preferred to rely on
future experimental means to associate the clusters with a
splicing factor, rather than to tease apart different splicing
factors binding to the same cluster. Alternatively, each
element could be treated as a separate ISRE, but for current
practical purposes, we believed our clustering procedure was
a reasonable intermediate approach.
Our strategy generated a ﬁnal set of 158 downstream (D1–
D158) and 156 upstream (U1–U156) mammalian ISREs. The
median number of words comprising each ISRE is ﬁve; the
smallest ISRE family consisted of two words, and the largest
family consisted of 32 words (Table S1 contains all down-
stream ISREs, and Table S2 contains all upstream ISREs).
Overall, 22% of the ;400 base intronic regions were perfectly
conserved across mammals, and the ISREs comprised 5.21%
(downstream) and 5.5% (upstream) of the conserved regions.
This implied that 1.1% to 1.2% of exon-proximal intronic
regions were evolutionarily preserved ISREs.
ISREs Resemble Known SREs
Here, we compare ISREs to known SREs. First, we used
positional distribution biases (described in Methods and
Materials) to identify ISREs that resembled canonical splicing
signals, namely 59 splice sites (59ss), 39 splice sites (39ss), and
branch signals, which we expected to be highly conserved
(Figure S2). A total of 17% (27 of 158) of downstream ISREs
resembled the major spliceosomal 59ss consensus (GT[A-
G]AGT), and 1.3% (two of 158) downstream ISREs resembled
the 59ss of the U12 minor spliceosome ([AjG]TATCCT) (see
Protocol S1 for a discussion of conserved U12-type introns).
Similarly, 1.3% (two of 156) upstream ISREs resembled the
39ss consensus (TTTCAG). The branch point signal was
detected as well (Table S2), peaking at ;15–40 bp from the
39ss (Figure S2) [30].
N e x t ,w ea s k e di fI S R E so v e r l a p p e dw i t hp r e v i o u s l y
published sets of SREs, other than canonical splice signals.
Three categories of k-mers representing exonic splicing
enhancers (ESEs) [9,10], exonic splicing silencers (ESSs)
[10,12], and intronic splicing enhancers (ISEs) [13] were
analyzed [31] (see Protocol S1 for details on the compilation
of the sets). We observed that a signiﬁcantly larger fraction of
ESS sequences matched upstream ISREs (Figure 1; 44% of 386
ESSs, compared with 21.5% 6 2% for random sequences; p ,
0.001), and a similar fraction matched downstream ISREs
(37% of 386 sequences, compared with 17% 6 1.8% for
random sequences; p , 0.001). Alternative splicing factors
such as Nova1 or Nova2 inhibited exon inclusion when bound
to Nova binding sites in the regulated exon, but modulated
exon inclusion/exclusion differently depending on whether
the binding sites are located in the upstream or downstream
intron [32,33]. Therefore, one can assign more than one role
to the Nova binding site, as being both an ESS and an intronic
regulatory sequence. Indeed, the Nova1/Nova2 binding site was
predicted as an ISRE, and also was present as an ESS [11]. Our
results suggest that in addition to being intronic modulators
of splicing, at least 53% (84) of upstream ISREs and 42% (67)
of downstream ISREs might have dual roles as ESSs (Tables S1
and S2 indicate the ISREs and their overlap with known
elements).
Next, we compared ISREs with ISEs, which were divided
into those that were downstream of 59ss (ISE5s) and those that
were upstream of 39ss (ISE3s) [13]. We observed a signiﬁcant
but small depletion of upstream ISREs in ISE3s: 17% of ISE3s
matched upstream ISREs, compared with 21.9% 6 2.3% for
random sequences (p , 0.05). Strikingly, only 5% of ISE5s
matched downstream ISREs, compared with 20.8% 6 3.5% (p
, 0.001). Similar results were observed when both ISE5s and
Figure 1. Overlap of ISREs with Known Classes of SREs, Namely ESE, ESS,
ISE5, and ISE3 Hexamers
Two sequences are defined as overlapping if one is a subsequence of the
other. The fraction of ISREs that overlap with a class of hexamers is
indicated in filled black bars. The white bars represent the mean fraction
of 1,000 comparisons of ISREs with sets of random hexamers of equal
size as the class (error bars depict one standard deviation). Refer to
Protocol S1 on details of the compilation of known splicing regulatory
sequences from multiple sources. ‘‘No SS’’ refers to using ISREs without
splice-site like sequences.
doi:10.1371/journal.pgen.0030085.g001
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upstream ISREs (p , 0.05, unpublished data) and a more
signiﬁcant depletion of downstream ISREs in all lSEs (p ,
0.001, unpublished data) in the combined set. ISEs were
originally computationally identiﬁed as sequence elements
that were more frequent in introns versus exons, and more
frequent in introns proximal to weak splice sites versus
introns proximal to strong splice sites ﬂanking constitutive
exons [34]. In addition, ISEs in mammals were more
frequently proximal to splice sites in short introns (,125
bases) relative to long introns (.1,000 bases) [13,34]. How-
ever, as alternative exons tend to be ﬂanked by signiﬁcantly
longer introns relative to constitutive exons [25–27], these
results suggest that ISREs are unlikely to have a role in
regulating constitutive exons, but that they are involved with
the regulation of alternative exons. In addition, the 3-fold
lower depletion of ISE5 sequences in ISREs compared with
ISE3 sequences suggested that splice site–speciﬁc regulatory
differences between alternative versus constitutive splicing
may exist at the 59ss. Finally, comparing the ISREs to ESEs
showed small differences (Figure 1). We concluded that while
a fraction of the identiﬁed ISREs resembled ESSs, most likely
do not function as known ESEs or ISEs, and were likely to
represent novel SREs.
ISREs Inhibit Intron-Proximal 59ss and 39ss
In order to test whether ISREs generally altered splicing in
human cells, we used previously published splicing reporters
[12]. Wang and colleagues observed that ESSs identiﬁed from
an experimental screen altered splice site choice by inhibiting
the intron-proximal splice site when inserted between
competing 59ss, with similar but weaker effects when inserted
between competing 39ss [11,12]. The authors also showed that
ﬁve out of ten ESEs enhanced use of the intron-proximal 59ss,
but had no appreciable effect on splice site choice in the 39ss
construct [12].
As the ISREs were signiﬁcantly enriched with published
ESS sequences, we reasoned that they would affect splice site
choice in a similar manner. A total of 80 constructs, including
previously published control elements [12], were generated
and transfected in triplicate into human 293T cells. Several
ISRE elements that resembled known elements, such as the
FOX1 binding site (UGCAUG) [35–38], the PTB binding site
(CU-rich) [39], and the Nova site (YCAY) [40], were included to
test their effects on splice site choice. We adopted an
identical strategy to that of the previous authors for
validating the ISREs [12] by generating most of the constructs
with a tandem duplication of the parent sequence of the ISRE
family. As many known alternative splicing factor binding
sites, such as CU-rich sites for PTB [39] and YCAY sites for
Nova [40], occurred in clusters, we believed that our
insertions, which ranged from ten to 14 bases, represented
accurate facsimiles of biological targets for the splicing
factors. As in the previous study, the insertions did not
overlap the proximal or distal 59ss or 39ss in the constructs
(Figure 2 and 3). For these experiments, we measured the
relative amount of the short (intron-distal) isoform as a
fraction of both isoforms. An ISRE could affect splice site
choice in two ways: (1) an ISRE could increase the preference
for the intron-distal splice sites by suppressing the intron-
proximal splice sites, resulting in a higher relative abundance
of shorter isoform; or (2) an ISRE could increase the
preference for the intron-proximal splice sites by suppressing
the intron-distal splice sites, resulting in more of the longer
isoform. For each inserted element, we asked if the ratios of
the intron-distal isoform relative to the sum of both isoforms
for an ISRE was signiﬁcantly different from the average ratio
of the controls by computing t test statistics, assuming that
the elements were independent and the ratios were normally
distributed. An ISRE was determined to suppress the intron-
proximal 59ss or 39ss if the mean was signiﬁcantly higher from
the average controls at a p-value cutoff of 0.01.
We observed that 83% (26 of 31) of the tested downstream
ISREs signiﬁcantly suppressed the intron-proximal 59ss in the
59ss reporter, compared with the average ratio of the control
elements (Figure 2). Negative control elements 1 to 3 were
randomly selected sequences that did not match ISREs, ESSs,
or ESEs; control elements 4 to 9 were the same as previously
published controls, which were neither ESSs nor ESEs [12].
Interestingly, control 9 (ATTTGATACC in Figure 2) was
revealed by our analysis to resemble a child of D111
(ATTTGAT). As predicted, this element also suppressed the
intron-proximal 59ss; thus, we did not consider it a valid
control element, reﬁning our validation rate to 84% (27 of
32). Of the remaining eight controls, only control element 4
suppressed the intron-proximal 59ss. Therefore, we con-
cluded that downstream ISREs were more likely to inhibit
intron-proximal 59ss (6- to 7-fold), relative to control
sequences.
Downstream ISRE TGCATG (D20), which was similar to the
FOX1/2 binding site UGCAUG [35–38], suppressed the intron-
proximal 59ss. Interestingly, two other clusters which bore
sequence similarity to D20, namely TGCAT (D89) and
GCATG (D50), differed signiﬁcantly in their ability to
suppress the intron-proximal 59ss when compared with
TGCATG (D20)—D89 exhibited stronger suppression (p ,
0.01), and D50 did not suppress the intron-proximal 59ss (p ,
0.001), which may reﬂect differences in the binding afﬁnity of
the splicing factor associated with the site. This observation
suggested that our clustering strategy, although overtly
conservative, had an advantage of allowing us to experimen-
tally reveal ISRE differences in splice site regulation between
closely related clusters. CU-rich motifs (D99) resembling the
PTB binding site, TCATTT (D19) resembling the Nova1 or
Nova2 binding sites, and a CTG-rich motif (D74, D103)
resembling the MBNL [41] or CELF protein-binding sites also
repressed the intron-proximal 59ss [42,43]. ACTAAC (D29),
which resembled the branch signal and was recently
identiﬁed to be enriched downstream of muscle-inclusive
alternative exons by Sugnet et al. [18], also suppressed the
59ss, which is to our knowledge the ﬁrst experimental
evidence that this motif affected 59ss selection in human cells.
We observed that 94% (34 of 36) of the upstream ISREs
signiﬁcantly suppressed the intron-proximal 39ss in the 39ss
reporter, compared with the average ratio of the controls
(Figure 3). Negative control elements 1 to 6 were the same as
previously published controls [12]. As an additional positive
control, we included a motif (GGGTGGGTGGG) that was not
present in our upstream ISREs but which had sequences that
resembled G triplets, a known intronic splicing enhancing
sequence [34]. This motif exhibited the strongest suppression
of the intron-proximal splice site. TTGCAG (U140), a novel
motif, exhibited the next strongest suppression of the intron-
proximal 39ss. We observed that two elements enriched in the
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GTGAG (U73). These elements also suppressed the intron-
proximal 39ss, suggesting that a splicing element resembling
the 59ss positioned close to the 39ss may be another
mechanism for alternative splicing regulation. A possible
role for splice site–like sequences in exon silencing has been
proposed previously [44,45]. Similarly, ISREs resembling
known splicing factor-binding sites, such as TGCATG (U25),
a CU-rich element (U118), a GU-rich element (U17), and
TCATTTT (U149), also suppressed the intron-proximal 39ss.
Expectedly, the element resembling the branch signal,
CTAAC (U22), did not alter the choice of 39ss. In contrast,
four of six controls exhibited signiﬁcantly greater use of the
intron-proximal 39ss—only two signiﬁcantly suppressed the
intron-proximal 39ss. If we compared the upstream ISREs
with control 3 (ACACGCGGGT), the control resulting in the
highest suppression of the intron-proximal 39ss, 79% (29 of
37, including the G triplet) of the upstream ISREs signiﬁ-
cantly suppressed the intron-proximal 39ss, relative to 0% (0
of 6) of the controls.
As the v
2 score distributions of the experimentally tested
ISREs and the remainder of the ISREs were not signiﬁcantly
different by a two-sample Kolgomorov-Smirnov test (p .
0.05), we concluded that 84% of tested downstream ISREs
and 94% of tested upstream ISREs altered splice site choice
in splicing constructs in human cells. Together with
published observations that ESE sequences identiﬁed by the
RESCUE-ESE method [9] tended to have an opposite effect
on 59ss selection and no pronounced effect on 39ss selection
compared with ESSs [12], our data supports a rule that ISREs
(like ESSs) generally inhibited intron-proximal splice sites. An
important caveat in our analyses is that the ISREs, which were
Figure 2. Downstream ISREs Alter Splice Site Choice
The 59ss reporter assay is depicted on the right. Boxes indicate exons, horizontal lines connecting the exons indicate introns; angled lines connecting
boxes represent splicing choices. The nucleotide sequence between the intron-proximal and intron-distal splice sites (indicated by arrows) is depicted.
ISREs indicated as a black bar are inserted in tandem duplicates between the competing 59ss. Each ISRE-containing reporter was transfected in triplicate
in human 293T cells. A representative PCR product for each ISRE-containing reporter is depicted on the etimidium bromide–stained agarose gel. The
larger and shorter bands on the gel correspond to the intron-proximal and intron-distal isoforms, respectively (indicated by arrows on the right of the
gel). Horizontal bars depict the mean of three replicates measuring the ratio between the intron-distal isoform to the sum of both isoforms. Error bars
depict one standard deviation. ctl indicates individual control elements. Asterisks on the right of each bar indicate ISREs that significantly altered
splicing relative to the averaged controls by a t test (p , 0.01). Please refer to Protocol S1 for details on quantification of the isoforms.
doi:10.1371/journal.pgen.0030085.g002
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in its natural context between competing splice sites. For
example, the recent study by Ule and colleagues demon-
strated that Nova could function as an activator or as a
repressor in a context-dependent manner [40]. Although the
ISREs generally suppressed the intron-proximal splice sites in
this particular context, they might have a different effect in
the same constructs in other cellular environments (i.e.,
varying concentrations of the relevant splicing factors).
Alternatively, the ISREs may also have a different effect
depending on the sequence context next to the ISRE. Future
analysis will be required to study these contextually depend-
ent effects on the regulation of splice site choice by ISREs.
ISREs Exhibit Strong Positional Biases
As SREs are known to have a positional preference near
splice sites [1,2,13,34], we asked if ISREs had positional biases
to be conserved at particular positions in the intron (;400
bases from the exon) relative to shufﬂed sequences control-
ling for the background levels of conservation. We incorpo-
rated the following observations in designing the shufﬂing
strategy. First, previous reports indicated that the amount of
ﬂanking intronic conservation was highest near the exon–
intron boundaries and diminished further away from the
exon [25–27]. Second, there are known preferences for
particular nucleotides to be enriched in intronic regions
close to the exons (such as G-rich tracts) [13,34]. To preserve
these attributes, original and shufﬂed sequences were
compared within relatively small windows (30 bases) as we
moved downstream (upstream) of the exon to retain the
overall positional biases of nucleotides. Exchanging nucleo-
tides from 300 bases away with sequences ten bases from the
splice sites would not be a sufﬁcient nor appropriate control
(nor would assuming a uniform distribution for each
element). Importantly, only nucleotides from perfectly con-
served regions were shufﬂed, retaining the positional bias for
conservation (i.e., a ﬁve-base conserved tract at position þ10
to þ14 of the downstream intron remained preserved across
mammals at the same position, but the nucleotides were
exchanged); this also preserved the conservational preference
for particular nucleotides.
The positional enrichment of each ISRE compared with
Figure 3. Upstream ISREs Alter Splice Site Choice
The 39ss reporter assay is depicted on the right. Boxes indicate exons, horizontal lines connecting the exons indicate introns; angled lines connecting
boxes represent splicing choices. The nucleotide sequence between the intron-proximal and intron-distal splice sites (indicated by arrows) are depicted.
ISREs indicated as a black bar are inserted in tandem duplicates between the competing 39ss (see legend to Figure 2).
doi:10.1371/journal.pgen.0030085.g003
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Intronic Splicing Regulatory Elementsshufﬂed controls was calculated (see Materials and Methods
and Protocol S1 for an example). We illustrate with three
ISREs in Figure 4. The FOX1 binding site (TGCATG, U25, and
D20) was enriched across the entire 400 bases of the ﬂanking
intronic region, and peaked at 15 to 150 bases near the splice
sites (Figure 4A). Unlike the FOX1 binding site, the motif that
resembled the branch signal (U22 and D29) had an
asymmetric distribution around exons (Figure 4B). The motif
is not enriched in most parts of the upstream intronic region,
but has a sharp peak of conservation at  40 to  10 bases
upstream of the 39ss, consistent with previous studies on the
location of the branch signal [13,46]. As expected, aside from
the branch signal, the 39ss and 59ss also exhibit sharp peaks of
positional enrichment (Figure S2). Noticeably, the motif also
had signiﬁcant biases 15–80 bases downstream of the 59ss,
consistent with results in a recent study [18]. Last, the motif
resembling the CUG-BP binding signal (U9 and D9) was
signiﬁcantly enriched in the ﬂanking intronic regions, with
strong peaks at  60 to 0 upstream of the 39ss and 0 to 120
downstream of the 59ss (Figure 4C). In summary, we
demonstrated that 84% (131 of 156) of the upstream ISREs
and 76% (120 of 158) of the downstream ISREs had
signiﬁcantly biased positional distributions, indicating that
most of the ISREs were likely to regulate splicing (Dataset S1
contains Z scores for all ISREs in the upstream and down-
stream intronic regions).
ISREs Are Enriched Near Alternative Exons
Next, we asked if candidate ISREs were enriched near AS
exons. Using available human transcript data, we generated a
high-quality set of ;13,650 mammalian conserved exons that
have evidence of exon skipping in humans. Next, we
generated separate sets of upstream and downstream intronic
regions from alternative exons (‘‘alternative’’ intronic re-
gions), and from constitutively spliced exons (‘‘constitutive’’
intronic regions). We calculated a Z score representing the
enrichment of every conserved 5- to 7-mers in the alternative
intronic regions as opposed to the constitutive intronic
regions, separately for upstream and downstream introns (see
Materials and Methods). A high Z score indicated that the k-
mer was enriched and conserved in alternative intronic
regions, and each ISRE set was represented by the maximum
Z score of an element in the set (Table S3). We note that as
the available transcripts do not afford complete coverage
across all biological conditions, the Z scores are likely
underestimates, as some constitutive exons are likely to be
AS in conditions with insufﬁcient transcript evidence.
We identiﬁed ISREs that had high enrichment scores near
alternative exons (Figure 5). We found that many of them
resembled known binding sites of splicing factors involved
with alternative splicing. For instance, the most enriched
elements in the downstream introns were the FOX1 binding
site TGCATG (D20) and its subsequence GCATG (D50), which
have been shown to be intronic splicing cis elements for the
mammalian ﬁbronectin and calcitonin/CGRP genes [35–37];
both mammalian FOX1 and FOX2 have been demonstrated to
regulate TGCATG-containing exons in human neuronal cell
cultures [47]. Our results indicate a potentially widespread
regulation of alternative splicing by the FOX1 family of
splicing regulators: 737 exons had a conserved TGCATG in
the downstream intron and 34% (248) had transcript
evidence for exon skipping, compared with 8.5% for the
entire set of exons (;13,650 of ;161,700 exons).
In addition, 39% (85 of 217) of mammalian exons with a
conserved ISRE ACTAAC (D29) in the downstream introns
had transcript evidence for exon skipping, a 5-fold enrich-
ment relative to 8.5%. This motif has recently been shown to
be enriched downstream of muscle-included alternative
exons [18], and the factor that binds the motif has not been
experimentally determined. ISRE TTTCAT (D150 and U149)
was associated with alternative exons: 13.6% (104 of 766) of
exons with conserved downstream TTTCAT and 14.7% (143
Figure 4. Conserved Positional Bias (Enrichment) Plots of ISREs
Conserved positional bias plots of ISREs in the intronic regions upstream
(black line) and downstream (red dashed line) of all exons (see Materials
and Methods). The PWM representation of the ISREs is depicted above
their respective plots.
(A) ISRE U25 and D20 resembled the FOX1 binding site (TGCATG) and
showed significant conserved enrichment throughout the 400 bases
flanking exons, as well as prominent peaks in the region 130 to 40 and
þ15 to þ120 of the intron.
(B) ISRE U22 and D29 resembled the branch signal (TACTAAC). U22
showed a prominent peak at 40 to 10. D29 was significant fromþ15 to
þ80.
(C) ISRE U9 and D9 resembled the ‘‘CUG’’ binding site of MBNL, and
showed significant conserved enrichment throughout the 400 bases
flanking exons. U9 peaked at  60 to 0 and D9 peaked at þ0t oþ120.
doi:10.1371/journal.pgen.0030085.g004
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transcript evidence for exon skipping, a 2-fold enrichment
compared with 8.5%. TTTCAT resembled the Nova binding
site. Nova1, a neuron-speciﬁc nuclear RNA binding protein,
was ﬁrst shown to recognize UCAU repeats by an immuno-
precipitation and afﬁnity elution-based RNA selection
procedure [48]. Further studies using ultraviolet cross-linking
and immunoprecipitation (CLIP) revealed that Nova proteins
regulate alternative splicing of ;30 transcripts [33], but our
method suggests many more potential Nova target exons.
We identiﬁed several motifs that contained a CTG motif
enriched in introns ﬂanking alternative exons. For instance,
14.7% (394 of 2,676) of exons containing downstream CTGCT
(D9), and 14% (402 of 2,868) of exons containing upstream
CTGCT (U9) had transcript evidence of exon skipping, 2-fold
enrichments compared with 8.5%. We believe that these
might be endogenous targets of the MBNL family of proteins.
MNBL had been shown previously to bind to stretches of
CUG repeats and to colocalize in vivo with CUG and CCUG
repeats in myotonic dystrophy cells [42,43]. A total of 12.8%
(638 of 4,978) of conserved exons proximal to TCTCT (U118)
and 12% (876 of 7,368) of conserved exons proximal to
TCTTT (U64) in the upstream alternative intronic regions
have evidence for exon skipping, 1.5-fold over 8.5%. These
resembled binding sites (UCUU and CUCUCU) for the PTB
family of splicing regulators. PTB was ﬁrst identiﬁed as a
regulator of the c-src N1 exon [49,50]. Last, 18% (168 of 937)
of exons proximal to TGTGTT (U17) have evidence of exon
skipping, compared with 8.5%, a 2-fold enrichment of the
motif. The GT-rich motif resembled the GU-rich binding site
of CELF/Bruno-like families of RNA binding proteins [51].
In summary, 56% (88 of 156) of upstream ISREs and 30%
(47 of 158) of downstream ISREs had a maximal Z score
greater than 4 (a Z score of 2.5 is associated with p , 0.01). Of
interest was our observation that downstream ISRE GTGAG
(D73) was the only ISRE that appeared overrepresented in
constitutive exons, due to its resemblance to the 59ss
consensus. Together, our results suggested that many ISREs
resembled known SREs involved with regulation of alter-
native splicing. In addition, the ISRE-proximal exons repre-
Figure 5. The Most Enriched ISREs Near Human AS Exons
The lengths of the horizontal bars represent the maximum Z score for the ISRE (see Table S3 for all ISREs enriched near AS exons; see Protocol S1 for Z
score calculation). The blue bars correspond to the downstream ISREs, represented by PWMs on the far left. PWMs were generated for each ISRE by
aligning all instances of sequences that make up the ISRE in the introns proximal to exons (see Protocol S1 for details). The red bars correspond to the
upstream ISREs, represented by PWMs on the far right. The PWMs are organized from most enriched (top) to least enriched (bottom) near AS exons.
PWMs are used here for visualization purposes.
doi:10.1371/journal.pgen.0030085.g005
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factors.
In a recent splicing-sensitive microarray study, Sugnet et al.
identiﬁed mouse alternative splicing events that were brain
and muscle speciﬁc [18]. Here, we asked if ISREs were
enriched in the ﬂanking introns of the putative brain- and
muscle-speciﬁc alternative events relative to a set of
constitutive exons. In agreement with their ﬁndings, we
observed that ISRE TGCATG was signiﬁcantly enriched in the
ﬂanking introns of brain-regulated exons; TCATTTT and
TTTCAT motif clusters were signiﬁcantly enriched in the
downstream introns of brain-included exons (Figure 6A); a
TGTTTC motif cluster was signiﬁcantly enriched in the
upstream introns of brain-included exons (Figure 6B), similar
to UG[CU]U[UG][UG][CG] identiﬁed in Sugnet et al. [18] and
the ACTAAC motif was signiﬁcantly enriched in the down-
stream introns of muscle-included exons similar to U[A/
C]C[U/A]AAC identiﬁed in Sugnet et al. [18] (Figure 6A). In
addition, we identiﬁed other ISREs that were signiﬁcantly
enriched or depleted in the ﬂanking introns of brain and
muscle alternative exons (Figure 6). Importantly, we observed
that the ISREs that were enriched proximal to tissue-speciﬁc
alternative exons altered splice site choice in human cells
(motifs highlighted in yellow in Figure 6). This suggests that
the splicing reporters in our assay were sensitive to changes
by elements that were typically used in tissue-speciﬁc
alternative splicing. With the availability of more splicing-
speciﬁc data across tissues, cell types, and developmental
stages, ISREs can be associated to various tissue-speciﬁc or
developmental stage–speciﬁc regulated exons.
Genes Containing ISRE-Proximal Exons Are Tissue Specific
and Have Molecular Biases
Motivated by the ﬁndings that Nova-regulated alternative
exons are expressed differentially in neurons and regulate
synapse formation [52], we hypothesized that other genes with
alternative exons containing common intronic regulatory
sequences may also exhibit tissue/cell type– or developmental
stage–speciﬁc expression, and share common molecular
functions. As preliminary analyses indicated that genes with
higher conservation in the noncoding regions were biased for
neuronal expression [53] (Figure S3), we designed a sampling
Figure 6. Enrichment and Depletion of ISREs Proximal to Alternative Exons Differentially Included or Skipped in Brain or Muscle from Splicing-Specific
Microarray Data
Intronic regions upstream and downstream of exons predicted to be included/skipped at different significance levels (see Protocol S1 for details on the
dataset). The significance of enrichment (red boxes)/depletion (green boxes) are reported as log10 p values; a plus sign indicates enrichment, and a
minus sign indicates depletion. For example, an ISRE represented by GCATG was enriched in intronic regions downstream of brain-included exons at p
, 1 3 10
 4 (reported as 4). The motifs highlighted in yellow have been experimentally verified to alter splice site choice in our reporter constructs.
(A) Downstream ISREs enriched/depleted in the downstream intronic regions.
(B) Upstream ISREs enriched/depleted in the upstream intronic regions.
doi:10.1371/journal.pgen.0030085.g006
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Intronic Splicing Regulatory Elementsstrategy to test for signiﬁcance of differential RNA expression
using a published survey of 79 human tissues and cell lines
[ 5 4 ] ,a sw e l la sG e n eO n t o l o g y (GO) categories, while
controlling for overall intronic conservation levels (see
Materials and Methods). For the purposes of our study, we
considered tissues/cell lines and GO terms signiﬁcantly
different (enriched/depleted) using a p-value cutoff of 0.001.
Using available RNA expression data [54], we found that
genes that have exons containing highly conserved TGCATG
(FOX1 binding) sites in the downstream intron were
signiﬁcantly biased for differential expression in many
regions of the brain (p , 0.001). In agreement, analysis of
the GO categories demonstrated signiﬁcant enrichment of
FOX1 candidate genes in potassium ion transport and
synaptic transmission (p , 0.001). Furthermore, genes with
exons containing TGCATG elements in the upstream introns
were also associated with high expression in the fetal brain,
occipital lobe, amygdala, prefrontal cortex, and uterus
(Figure 7A). This was consistent with the tissue-speciﬁc
expression of FOX1 in the brain (Figure S4).
Genes that contained conserved TTTCAT (D150, Nova1,
and Nova2 binding sites) in the downstream introns exhibited
signiﬁcant bias in the superior cervical ganglion, smooth
muscle, CD34
þ bone marrow cells, and fetal brain, and were
depleted in heart, lung, and lymphoma Burkett Raji cells
(Figure 7A). This was consistent with the expression patterns
of both genes (i.e., Nova1 is highly differentially expressed in
all these tissues except in fetal brain, and is expressed less in
heart and lung; Nova2 is expressed highly in the superior
cervical ganglion and CD34
þ bone marrow cells, and is
expressed less in smooth muscle cells and the lung; Figure S4).
In addition, TTTCAT-containing introns were enriched in
genes overrepresented in mRNA splicing. Surprisingly, in
addition to being expressed highly in CD34
þ bone marrow
cells and B lymphoblasts, genes that contain TTTCAT sites
(U87, U149) in the upstream introns of exons were
signiﬁcantly enriched in various subregions of the brain
(occiptal and parietal lobes, cingulated cortex, superior
cervical ganglion, and prefrontal cortex; Figure 7B). This
may reﬂect differences in the regulation of alternative
splicing, which depended on the binding of Nova1o rNova2
to YCAY sites in the upstream or downstream intronic
regions [40]. Last, conserved CT-rich motifs (U118), resem-
bling binding sites for PTB and its neuronal paralog, were
enriched in the upstream introns of exons in genes that were
expressed highly in various regions of the brain, and were
signiﬁcantly underrepresented in genes that were expressed
in cells and tissues of the immune system. This is consistent
with the expression of PTB and nPTB: PTB is expressed highly
in the immune system and signiﬁcantly depleted in the brain
and subregions of the brain, and nPTB is enriched in both the
brain and subregions of the brain (Figure S4). As nPTB is
known to antagonize PTB binding [55], this suggested that
PTB and nPTB might coordinately regulate target genes to
achieve tissue-speciﬁc alternative splicing in a widespread
manner.
ISREs in Figure 7 were not isolated examples. In total, 113
of 158 downstream ISREs (71%) and 126 of 156 upstream
ISREs (81%) exhibited differential gene expression biases
(Table S4 contained enriched GO terms associated with
ISREs, and Table S5 contained expression biases associated
with ISREs). A few studies had analyzed correlations between
splicing and transcription in the global regulation of gene
expression: for example, Johnson and colleagues observed
that similar tissues have similar patterns of alternative
splicing [5]; Pan and colleagues showed that AS proﬁles
reﬂected tissue identity [22]. However, these correlations
were performed on expression-level data, independent of the
splicing factors or splicing cis elements that regulate the
exons. Here, an alternative way of analyzing the correlation
between transcription and alternative splicing was suggested.
Our analysis revealed that exons that had conserved ISREs in
common were found in tissue-speciﬁc, functionally coherent
groups of genes. If we assume that the ISREs were bound by
several known and as yet unidentiﬁed splicing factors, this
implies that the exons with common ISREs are likely
coordinately regulated. Although the associations described
here between transcription and splicing are likely to be
coincident (similar to Nova [52]) rather than a mechanistic
interaction between the transcriptional machinery and
splicing factors, our results provide preliminary evidence
suggesting that the regulation of alternative splicing by ISREs
are widespread in tissue-speciﬁc, functionally biased genes.
Conserved ISREs and ACEs Predict Autoregulation of
Splicing Factors and the Cognate RNA Binding Site
Several proteins have been reported to affect their own
alternative splicing, including PTB, Nova1, ADAR2, hnRNP A1,
Srp20, SC-35, TIA1 and TIAR, and FOX2 [32,56–62]. Inter-
action of the protein with its own pre-mRNA via its RNA
binding sites typically causes alternative splicing of an exon
that generates an isoform containing a premature termina-
tion codon. Autoregulation by alternative splicing might
usher candidates down the nonsense-mediated decay pathway
[62], potentially regulating the amount of splicing factor
available in the cell. Alternatively, autoregulation may also
lead to an inactive form of a protein [56].
Evolutionarily preserved AS exons have high sequence
conservation in the ﬂanking intronic sequences [25,26],
which, together with additional features such as exon and
intron length, splice site strength, and k-mer counts, enabled
the genome-wide identiﬁcation of alternative conserved
exons (ACEs) in human and mouse genes with the algorithm
ACEScan [27,63]. An updated genome-wide ACEScan analy-
sis, consistent with our previous results [27], indicated that
Figure 7. Several Examples of GO and Tissue Expression Biases for Genes Containing ISRE-Proximal Exons
A gene is defined as differentially expressed in a specific tissue or cell line if its expression in the tissue or cell line is two standard deviations above the
median expression across all tissues/cell lines. We denote genes that contain ISRE-proximal exons as ISRE genes. For each ISRE, the tissues or cell lines in
which the ISRE genes were significantly enriched (positive value) or depleted (negative value) are illustrated, followed by the enriched or depletedG O
terms. The y-axis is the log10 p value for significance. For notational simplicity, a minus sign indicates significantly depleted values. Please refer to
Protocol S1 for details on controlling for background conservation in the intronic sequences.
(A) Downstream ISREs.
(B) Upstream ISREs.
doi:10.1371/journal.pgen.0030085.g007
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ries, for RNA binding and mRNA splicing (Figure S5). This
was in agreement with a study analyzing ultraconserved
elements (UCEs), which identiﬁed ;200-bp long sequences
that are 100% conserved in orthologous segments of human,
mouse, and rat genomes [64]. The authors had discovered that
the exon-overlapping UCEs were often located in genes
involved in RNA binding and regulation of splicing [64]. Not
surprisingly, there is substantial overlap of ACEs and UCEs
(i.e., 49 of 65 UCEs that map to internal exons have positive
ACEScan scores; Table S6). However, very little is known
about why the ﬂanking introns have such a high degree of
Figure 8. ISREs Proximal to Alternative Exons in Splicing Factors Resemble its RNA Binding Sites
A total of 400 bases of intronic region flanking each internal exon were extracted for each splicing factor. Each box in the grid represents the total
number of nonoverlapping occurrences of the conserved ISRE (either upstream ISRE or downstream ISRE) in the flanking intronic regions. ISREs that
occur at least once in the flanks of at least one exon are retained in the grid. The exon–intron structure of selected exons are depicted below each grid.
Tall vertical rectangles depict exons, and interconnecting lines represent introns; the line connecting nonadjacent exons represents alternative splicing
of the middle exon. Red bars proximal to the alternative exon illustrates the ISRE. The level of conservation across multiple species (from the hg17 UCSC
genome browser) is depicted below the exon.
(A) Nova1: U149 (TTTCAT) and D150 (TTTCAT) are the most abundant ISREs in the flanking intronic region of exon 4. The flanking intronic region of exon
4 has the highest sequence conservation across mammalian genomes among all flanking intronic regions in Nova1.
(B) FOX1: U25 (TGCATG) and D20 (TGCATG) are the most abundant ISREs in the flanking intronic region of exon 10 in FOX1. The flanking intronic region
of FOX1 has the highest sequence conservation among all flanking intron regions in FOX1. The exon 10 sequence (boxed) and 15 bases of flanking
intronic regions are depicted below the exon–intron structure of exons 9, 10, and 11. TGCATG sites (in red) are overlapping the 59ss and 39ss.
(C) nPTB: exon 10 of nPTB has transcript evidence for alternative splicing, and contained highly abundant U26 (TTCTT), U121 (TGTCT), U122 (TTCCTT),
U149 (TTTCAT), D21 (TTCCTT), D108 (TCCTTT), D115 (TGTCT) and D150 (TTTCAT).
(D) hnRNP C: the flanking intronic regions of exon 2 of hnRNP C contains 17 copies of TTTTT (an element in U4), and is the most highly conserved among
the intronic regions in hnRNP C.
doi:10.1371/journal.pgen.0030085.g008
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dary structure may be under selection, or that splicing
regulatory motifs are being preserved [25,26].
Here, we suggest a strategy to use ISREs to discover the
binding sites of splicing factors, based on this broad notion
that splicing factors regulated their own alternative splicing.
We illustrate with four splicing factors, Nova1, nPTB, FOX1,
and hnRNP C. In published work, high-afﬁnity Nova-binding
sites (YCAY) were identiﬁed within exon E4 of Nova1, which
extended into the intronic region downstream of E4.
Although the intronic elements themselves were shown to
be insufﬁcient for mediating Nova-dependent E4 inhibition,
they are synergistic to E4 in enhancing Nova-dependent
repression [32]. When we counted the ISREs in the upstream
and downstream intronic regions (400 bases each) of the
internal exons in Nova, we found that the ISRE TTTCAT,
resembling the Nova site, occurred with the highest frequency
in E4 compared with all other ISREs (Figure 8A). Our second
example is the FOX1 gene. We discovered that exon 10 (93 bp
in length) contained ﬁve conserved TGCATG sites in the 400
bases ﬂanking the exon, the highest density of mammalian-
conserved TGCATG binding sites in this region, in the
genome (Figure 8B). Closer examination of the exon showed
that TGCATG overlapped both the 59ss and the 39ss in a
similar arrangement to the autoregulated exon in its paralog
FOX2 [56]. In addition, these TGCATG sites were conserved
from human to Xenopus tropicalis (but not in tetraodon). Exon
10 encodes RNP1, one of the two most critical motifs of the
RRM, and is skipped in skeletal muscle [65]. The third
example is the nPTB, which, like its paralog polypyrimidine
tract binding protein (PTB), also bound CU-rich motifs [39].
PTB was shown to autoregulate itself by binding to CU-rich
motifs in an exon leading to a nonsense-mediated decay
candidate. Here we observed that exon 10 (34 bp) of nPTB,
which is excluded in nonneuronal tissues [66], contained high
numbers of conserved TTCTT, TTCCT, and TCCTTT ISREs
in the ﬂanking introns (Figure 8C). Noticeably, ISRE TTTCAT
(resembling Nova sites) were also present (more than ﬁve
copies) in the ﬂanking introns, indicating that in this
example, we narrowed down the potential binding site to
two motifs. Last, heterogeneous ribonucleoprotein C (hnRNP
C) contained an AS exon 2 (evidence from Mammalian Gene
Collection clones BC007052, BC008423, and BC089438) that
had 17 copies of mammalian conserved TTTTT (contained in
ISRE TTTTTC) in the ﬂanking introns (Figure 8D). Exclusion
or inclusion of the 26-bp long exon alters the reading frame
and generates a premature termination codon. This is further
supported by a study indicating that the hnRNP C binding site
obtained by SELEX is indeed a stretch of 5 U residues [67].
Interesting, all examples shown here have high sequence
conservation in the intronic regions proximal to the
identiﬁed exons (Figure 8A–8D). Importantly, we found that
these exons had positive ACEScan scores (NOVA1: 0.38; FOX1:
1.24; nPTB: 1.88; hnRNP C: 0.26) [27]. We suggest that we can
ﬁrst predict conserved alternative exons in splicing factors
with ACEScan. Next, by enumerating the occurrences of
ISREs proximal to the alternative exon, we can computation-
ally predict the binding site of the splicing factor. To our
knowledge, this particular computational application has not
been reported for any trans-factor before. Whether this
observation is general for all splicing factors remains to be
seen, and warrants further investigation.
Conclusion
The key ﬁndings of this work are the following. First, it
reveals a set of evolutionarily conserved ISREs, and hundreds
of candidate ISRE-regulated exons conserved across mamma-
lian genomes. Second, 84% and 94% of tested ISREs were
shown to suppress intron-proximal 59ss and 39ss in competing
splice site reporter constructs in human cells, demonstrating
that most ISREs can affect splicing. Combined with computa-
tional evidence that ISREs are enriched for sequences that
resembled ESSs, our results suggest that a subset of ISREs
might play dual roles as ESSs. Third, ;30%–50% of ISREs
were enriched near alternative exons, of which several
resembled most of the known binding sites of tissue-speciﬁc
splicing factors. In addition, we show that ISREs were
enriched near tissue-speciﬁc alternative events. Fourth, we
found that for most ISREs, human genes containing ISRE-
proximal exons had strong tissue expression and functional
biases. Furthermore, for several ISREs that resembled known
binding sites, the tissue-speciﬁc expression biases of the
target genes reﬂected the expression of the splicing factors in
a panel of human tissues. Finally, we present a novel strategy
that uses ISREs and exploits the observation that many
splicing factors are autoregulated to predict the binding
site(s) of four splicing factors: Nova1, nPTB, hnRNP C, and
FOX1. Taken together, we believe that ISREs are cornerstones
in the understanding of general and tissue-speciﬁc alternative
splicing. With the growing interest and importance in the
detection and regulation of cell type– and stage-speciﬁc
alternative splicing, ISREs will be crucial in teasing apart the
combinatorial regulation of alternative events [8].
The importance of identifying SREs is underscored by the
observation that as many as 50% of disease mutations in
exons may affect splicing [8]. In addition to mutations that
affect exonic splicing elements, we believe that, as ISREs are
highly conserved across mammalian evolution, have strong
positional biases, and are enriched near alternative exons,
mutations in ISREs will also alter splicing. We believe
knowledge of ISREs will shed light on a currently unappre-
ciated area of human disease. Last, in the near future, we will
determine the splicing trans-factors that bind to each ISRE,
and, armed with the networks of ISRE-proximal exons, we will
be able to achieve a global ‘‘RNA map’’ [40].
Materials and Methods
Databases. Genome sequences and alignments: The genome sequences
of human (hg17), dog (canFam1), mouse (mm5), and rat (rn3) were
obtained from the University of California Santa Cruz (UCSC), as
were the whole-genome multiz and pairwise alignments (http://
genome.ucsc.edu). The four-way mammalian (4-mammal) whole-
genome alignment (hg17, canFam1, mm5, rn3) was extracted from
the 8-way vertebrate multiz alignments (hg17, panTrol1, mm5, rn3,
canFam1, galGal2, fr1, danRer1).
Exon and intronic datasets: The lists of known human genes (obtained
March 2005; knownGene.txt.gz, obtained from the UCSC ftp server
[http://hgdownload.cse.ucsc.edu] containing 43,401 entries) and
known isoforms (knownIsoforms.txt.gz; containing 43,286 entries in
21,397 unique isoform clusters) with annotated exon alignments to
human hg17 genomic sequence were processed as follows. Con-
servatively, known genes that were mapped to different isoform
clusters were discarded. All mRNAs aligned to hg17 that were greater
than 300 bases long were clustered with the known isoforms. Genes
containing less than three exons were also removed from further
consideration. The 59 and 39 ends of introns were required to be U1-
or U12-type splice sites. For each internal exon, 400 bases of ﬂanking
intronic regions were extracted from the alignments.
Conservation scores. The conservation score (S) of a sequence
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2
statistic with Yates correction, computed from the two-by-two
contingency table, T (T11: number of occurrences of the element
perfectly conserved across alignments; T12: number of occurrences of
all other conserved elements of similar length; T21: number of
occurrences of element in the reference genome only [human]; T22:
number of occurrences of all other elements of similar length in the
reference genomes). Counts in the table had to be greater than ten.
To correct for multiple hypothesis testing, p values were multiplied
by the total number of comparisons. Enriched elements with
corrected p values less than 0.001 were considered signiﬁcant.
Experimental validation of ISREs in splicing-sensitive constructs.
We obtained previously published splicing reporters with competing
59ss or 39ss [12]. ISRE sequences were duplicated and inserted
between two competing splice sites by restriction enzyme digestion
and ligation. 293T cells were cultured with D-MEM supplemented
with 10% fetal bovine serum. Transfections were carried out with
Fugene (Roche, http://www.roche.com) in 24-well culture plates. A
total of 0.2 lg DNA (construct) was incubated with 1 ll Fugene
reagent in 20 ul serum-free media for 20–60 min at room temper-
ature before transfection into the cells. After 48 h, cells in each well
were lysed in 300 ml RNA-bee (Teltest, http://www.tel-test.com). Total
RNA was isolated by chloroform extraction of the aqueous phase,
followed by isopropanol precipitation as per the manufacturer’s
instructions. The RNA was washed in 75% ethanol and eluted in
DEPC-treated water before treatment with RQ1 DNAase (Promega,
http://www.promega.com). The reverse transcription (RT) reaction
was carried out by using 2 lg total RNA with SuperScript III
(Invitrogen, http://www.invitrogen.com). One-tenth of the product
from the RT reaction was used for PCR (20–25 cycles of ampliﬁca-
tion). PCR products were run on 2% agarose gels, and the gels were
scanned by a ﬂuorescence detection imager (Fuji, http://www.fujimed.
com). For each PCR product, three electronic boxes of equal size were
drawn on the images: one box surrounded the larger product (intron-
proximal splice site was used), one box surrounded the smaller
product (intron-distal splice site was used), and one box was situated
above both products to measure the background ﬂuorescence in the
gel (‘‘background’’). We calculated the amount of splicing change—
the fraction of intron-distal isoform out of both isoforms—as (intron-
distal/background)/(intron-distal/background þ intron-proximal/
background).
Calculation of Z score for enrichment near AS exons. Human exons
with transcript evidence (human mRNAs and ESTs) for exon
inclusion/exclusion were designated as skipped exons. Constitutive
exons are exons with no evidence for alternative splicing (alternative
39ss usage, 59ss usage, intron retention, or mutually exclusive exons).
We generated separate datasets for the upstream and downstream
intronic regions (400 bases) ﬂanking skipped exons. A similar dataset
was generated for constitutive exons. Next, the human intronic
regions were aligned to orthologous intronic regions in human, dog,
rat, and mouse. The alternative splicing conservation enrichment
score of a sequence element of length k (k-mer) was represented by
the nonparametric v
2 statistic with Yates correction, computed from
the two-by-two contingency table, T (T11: number of occurrences of
the element perfectly conserved across alignments proximal to
skipped exons; T12: number of occurrences of the element in human
proximal to skipped exons; T21: number of occurrences of element
perfectly conserved across alignments proximal to constitutive
exons); T22: number of occurrences of the element in human
proximal to constitutive exons). Counts in the table had to be greater
than ﬁve. The ﬁnal score for each ISRE was the maximum Z score (v
value) associated with a sequence element from the set of sequences
representing the ISRE.
Calculation of enrichment proximal to tissue-speciﬁc alternative
exons. To determine the enrichment or depletion of ISREs in mouse
introns proximal to tissue-speciﬁc alternative exons, we ﬁrst
computed F, the frequency of an ISRE in a set of sequences of size
N. For each r of 5,000 random selections (R¼5,000), N sequences are
randomly chosen from the control set and Gr, the frequency of an
ISRE in the random set R, is computed. The p value for enrichment of
an ISRE is computed as (1 E/R), where E is the number of times that
(F . Gr). The p value for depletion is computed as (1 D/R), where D
is the number of times that (Gr . F). Due to the small numbers of
muscle-skipping events, the p values for depletion are not reliable,
and hence the muscle-skipping events are excluded.
GO and tissue expression analysis. We calculated the level of
sequence conservation 400 bases upstream and downstream, sepa-
rately for all exons. Exons are binned into one of six upstream (or
downstream) intronic conservation bins: 10%–20%, 21%–30%,
31%–40%, 41%–50%, 51%–60%, and 61%–100%. GO identiﬁers
(IDs) for each Refseq-annotated gene were obtained from EnsMart
(June 2005 release; http://www.ensembl.org). Organizational princi-
ples (molecular function, biological process) were obtained from
http://www.geneontology.org. For each conserved motif M,w e
identiﬁed all exons that have the motif M conserved in the 400
bases upstream (or downstream) of the exon (M exons), and the
corresponding genes that contain these exons (M genes). Next we
calculated, for each GO term (e.g., neurogenesis, GO ID: 0007399),
FM,GO, the fraction of M genes associated with the term. Next, M
exons were grouped into bins by their level of upstream (or
downstream) intronic conservation (as above). For 10,000 iterations,
we took a similar number of randomly chosen background exons
with the same upstream (or downstream) intronic conservation level
from the background set (B exons). This controlled for the level of
intronic conservation of the upstream (or downstream) introns. After
retrieving the corresponding background genes (B genes), we
determined FB,GO, the fraction of background genes that are
associated with each GO term. The p value for the signiﬁcance of
enrichment (or depletion) for each GO term was computed as 1  N/
10,000, where N was the number of iterations where FM,GO . FB,GO
(or FM,GO , FB,GO for depletion). Affymetrix HG-133A and GNF1B
microarray gene expression from 79 human tissues and cell lines
previously published by Su and colleagues [54] were obtained from
the Gene Expression Atlas (http://expression.gnf.org). Mappings for
Affymetrix probe identiﬁers were obtained from EnsMart (release
19.1). Average difference values lower than 20 were standardized to
20, as described [54]. Genes expressed in a tissue or cell line at
greater than two standard deviations above the median expression
across tissues or cell lines were deﬁned as tissue-speciﬁcally
expressed in that tissue or cell line. The analysis was similar to the
GO analysis, except with tissue type instead of GO term. GO term
and tissue/cell lines that were signiﬁcantly different (p , 0.001) were
retained.
Supporting Information
Dataset S1. Z Scores Representing Positional Biases of ISREs in
Downstream and Upstream Introns
Found at doi:10.1371/journal.pgen.0030085.sd001 (225 KB XLS).
Figure S1. Steps for Score-Based Clustering Algorithm
(1) Backwards grouping, comparing short k-mers to longer k-mers.
Shorter k-mers are designed as parents of longer k-mers if the k-mer
is a subsequence of, and has a higher enrichment score than the
longer k-mer.
(2) Forward grouping, comparing long k-mers to shorter k-mers that
are not already parents. Shorter k-mers are a child of a longer k-mer
if it is a subsequence of and has a lower enrichment score than the
longer k-mer. In our example, TTGGT (score of 47), TTGGTT (score
of 52), and TGGTTT (score of 78) are parents, with children (above
them) designated by the connected green boxes (full lines, dashed
lines, and spotted lines, respectively).
(3) Families are combined if more than half of the children are
shared, designating the higher-scoring parent as the new parent. In
our example, TTGGT (score of 47, which is less than 52) and children
are collapsed into TTGGTT (score of 52), with TTGGTT as the new
parent.
(4) Families are combined if parent sequences are similar in sequence,
and children of the lower-scoring parent match the sequence of the
higher-scoring parent.
(5) Children that have more than one parent are uniquely associated
with the higher-scoring parent.
(6) Members of each family are weighted by the number of
occurrences in the genome and aligned, generating position-speciﬁc
weight.
Found at doi:10.1371/journal.pgen.0030085.sg001 (251 KB PDF).
Figure S2. Canonical Splice Signals Exhibit Strong Positional
Enrichment
Positional bias (Z scores) were computed as described in Protocol S1.
Found at doi:10.1371/journal.pgen.0030085.sg002 (259 KB PDF).
Figure S3. Inherent Biases for Tissue Expression in Genes Containing
Exons with Different Degrees of Intronic Conservation (400 Bases
Upstream or Downstream of the Exon)
Upstream and downstream introns are binned into six bins of
conservation (10%–20%, 21%–30%, 31%–40%, 41%–50%, 51%–
60%, and 61%–100%). The tissues represent the top ten tissues
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Intronic Splicing Regulatory Elementsenriched in genes from random samplings in the respective bins
relative to all the genes. Tissues with asterisks are signiﬁcantly
enriched at p , 0.05.
Found at doi:10.1371/journal.pgen.0030085.sg003 (183 KB AI).
Figure S4. Gene Expression Proﬁles of Nova1, Nova2, PTB1, nPTB, and
FOX1 Across Human Tissues from Available Microarray Data
Average difference values (log base 2) are plotted on the y-axis; tissues
and cell lines are depicted on the x-axis.
Found at doi:10.1371/journal.pgen.0030085.sg004 (32KB PDF).
Figure S5. GO Categories that Are Signiﬁcantly Different in Genes
Containing Predicted ACEs Compared with Genes that Do Not
Contain Predicted ACEs
Found at doi:10.1371/journal.pgen.0030085.sg005 (189 KB PDF).
Table S1. Downstream ISREs and Overlap with Known SREs
Parents and children comprised each ISRE identiﬁed by our method.
ESSs, ESEs, ISEs, and canonical splice signals (59ss, 39ss, and branch
signals) that overlapped ISREs are listed (see Protocol S1 for how
sequence overlap is determined).
Found at doi:10.1371/journal.pgen.0030085.st001 (221 KB DOC).
Table S2. Upstream ISREs and Overlap with Known SREs
Parents and children comprised each ISREs identiﬁed by our method.
ESSs, ESEs, ISEs, and canonical splice signals that overlap ISREs are
listed (see Protocol S1 for how sequence overlap is determined).
Found at doi:10.1371/journal.pgen.0030085.st002 (310 KB DOC).
Table S3. Z Scores Representing the Enrichment of ISREs Proximal to
AS Exons in the Downstream Intronic Region (Downstream ISRE) or
Upstream Intronic Region (Upstream ISRE)
The highest Z score for the ISRE and the k-mer with the highest Z
score are represented in the last two columns (see Protocol S1 for
calculation of the Z scores for each ISRE).
Found at doi:10.1371/journal.pgen.0030085.st003 (175 KB DOC).
Table S4. GO Terms that Are Signiﬁcantly (p , 0.001) Enriched in
Genes Containing Downstream ISRE-Proximal Exons (D1–D158) and
Upstream ISRE-Proximal Exons (U1–U156)
Parents are indicated here to represent the ISRE.
Found at doi:10.1371/journal.pgen.0030085.st004 (488 KB DOC).
Table S5. Tissue-Expression Biases of Genes
Shown are tissue-expression biases of genes containing (A) down-
stream ISRE-proximal exons and (B) upstream ISRE-proximal exons.
Found at doi:10.1371/journal.pgen.0030085.st005 (145 KB PDF).
Table S6. UCEs that Overlap ACEScan-Positive Exons (hg17
Coordinates)
Found at doi:10.1371/journal.pgen.0030085.st006 (104 KB DOC).
Protocol S1. Supplementary Information for Evolutionarily Con-
served Mammalian ISREs
Found at doi:10.1371/journal.pgen.0030085.sd002 (64 KB DOC).
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